VT
WST icon

Vise Technologies’s West Pharmaceutical WST Stock Holding History

Vise Technologies’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$229K Hold
834
– – ﹤0.01% 1308
2025
Q4 		$229K Sell
834
-16
-2% -$4.38K ﹤0.01% 1318
2025
Q3 		$223K Buy
+850
New +$207K 0.01% 1069
2024
Q4 		$203K Buy
+619
New +$195K 0.02% 775

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vise Technologies's WST Position: Q1 2026 in Review

Vise Technologies held its West Pharmaceutical (WST) position steady in Q1 2026 at 834 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #1308.

Vise Technologies first reported a position in WST in Q4 2024 and has held it in 4 quarters since. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Vise Technologies held 834 shares of West Pharmaceutical worth $229K as of Q1 2026.
  • Vise Technologies left its West Pharmaceutical share count unchanged in Q1 2026.
  • West Pharmaceutical made up ﹤0.01% of Vise Technologies's portfolio in Q1 2026, its #1308 holding.
  • Vise Technologies first reported a position in West Pharmaceutical in Q4 2024 and has held it in 4 quarters since.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.